Painkiller Maker Seeks Review Of Obviousness Inquiry In Patent Case
(September 15, 2016, 3:24 PM EDT) -- WASHINGTON, D.C. — Following an appellate court’s decision that four patents covering the pain-relieving drug OxyContin are invalid, a painkiller manufacturer in a Sept. 1 petition for writ of certiorari asks...
To view the full article, register now.
Try for FREE for fourteen days
Already a subscriber? Click here to login